Fizazi, et al. ARAMIS: Efficacy and safety of darolutamide in nonmetastatic castration-resistant prostate cancer (nmCRPC). ASCO-GU 2019, abstract 140.
Effect van HPV-vaccinatie in Engeland over sociaaleconomische groepen
sep 2024 | Gynaecologische oncologie, Vaccinatie, Virale infecties